SAV005-02: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of AeroVanc for the treatment of Persistent Methicillin-Resistant Staphylococcus aureus Lung Infection in Cystic Fibrosis Patients

      Project: Research project

      Project Details

      StatusFinished
      Effective start/end date11/4/1312/31/15

      Funding

      • Savara Inc.
      • Savara Inc.